Muñoz Martín, Andrés J. http://orcid.org/0000-0001-6977-8249
Ruiz Zamorano, Magdalena Carmen
Viñuela Benéitez, María Carmen
Ortega Morán, Laura
García Pérez, Ángela
Martín Jiménez, Miguel
Article History
Received: 12 January 2019
Accepted: 5 June 2019
First Online: 13 June 2019
Compliance with ethical standards
:
: Andrés J. Muñoz Martin: Dr. Muñoz has received speakers’ honoraria or honoraria for participation in Advisory Boards from Sanofi, Celgene, Leo Pharma, Daiichi Sankyo, Pzifer-BMS, Rovi, Celgene, Shire, Astra-Zeneca and Medscape and research grants from Sanofi and Leo Pharma. Magdalena Carmen Ruiz Zamorano, María Carmen Viñuela Benéitez, Laura Ortega Morán and Ángela García Pérez declare that they have no conflict of interest. Dr. Miguel Martín Jiménez: Dr. Martin has received speakers’ honoraria or honoraria for participation in Advisory Boards from AstraZeneca, Novartis, Roche-Genentech, Pfizer Glaxo, Pharmamar, Taiho Oncology and Lilly, and research grants from Novartis and Roche.
: Informed consent was obtained from all individual participants included in the study.
: The study was approved by the Ethics Committee of Hospital General Universitario Gregorio Marañón, Madrid, Spain. The study has been approved by the appropriate institutional and/or national research ethics committee and has been performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.